T. Harayama et al. / Tetrahedron 60 (2004) 1611–1616
1615
1
3.4. General procedure for the coupling reaction of
1-halobenzyldihydroindole derivatives (16 and 17) in the
presence of phosphine ligand
(KBr) cm21: 1240, 1035. H NMR (500 MHz, CDCl3) d:
0
5.29 (2H, s, Ar–CH2–N), 5.89 (2H, s, C2 –H), 6.06 (1H, d,
J¼3.5 Hz, C3–H), 6.58 (1H, d, J¼3.5 Hz, C2–H), 7.04 (1H,
0
0
s, C4 –H), 7.12 (1H, s, C7 –H), 7.13 (1H, ddd, J¼1.0, 7.0,
8.0 Hz, C5–H), 7.19 (1H, ddd, J¼1.0, 7.0, 8.0 Hz, C6–H),
7.25 (1H, dd, J¼1.0, 8.0 Hz, C7–H), 7.66 (1H, dd, J¼1.0,
8.0 Hz, C4–H). FAB-MS m/z: 329 (M)þ, 331 (Mþ2)þ.
Anal. calcd for C16H12BrNO2: C, 58.26; H, 3.66; N, 4.24.
Found: C, 58.27; H, 3.93; N, 4.11.
Each compound (16 or 17) (0.3 mmol) was reacted with
Pd(OAc)2, a phosphine ligand, and a base in dry DMF
(8 ml) using Pd(OAc)2 and the phosphine ligand in the
ratios indicated in Tables 1 and 2, and 200 mol% of base for
the times and temperatures indicated in the tables. Then, the
reaction mixture was diluted with AcOEt and the precipitate
was removed by filtration. The filtrate was washed with
aqueous 5% NaOH solution and brine. The residue from 16
was dissolved in CHCl3 and subjected to column chroma-
tography through Al2O3. Elution with hexane–AcOEt
(50:1) gave 20 and elution with hexane–AcOEt (30:1)
gave 21a. Moreover, elution with hexane–AcOEt (15:1)
gave 1 and elution with AcOEt gave 3.
The residue from 17 was dissolved in CHCl3 and subjected
to column chromatography through silica gel. Elution with
hexane–AcOEt (15:1) gave 22. Successive elution with the
same solvent gave 23 and 2, and elution with AcOEt gave 4.
3.4.6. Assoanine (2). Pale yellow needles, mp165.5–168 8C
1
(EtOH), (lit.20b 175–176 8C). H NMR (200 MHz, CDCl3)
d: 3.03 (2H, t, J¼7.8 Hz, C4–H), 3.34 (2H, t, J¼7.8 Hz,
C5–H), 3.90 (3H, s, OCH3), 3.95 (3H, s, OCH3), 4.12 (2H, s,
C7–H), 6.67 (1H, s, C8–H), 6.78 (1H, dd, J¼7.4, 7.6 Hz,
C2–H), 7.01 (1H, dd, J¼1.0, 7.4 Hz, C3–H), 7.19 (1H, s,
C11–H), 7.34 (1H, dd, J¼1.0, 7.6 Hz, C1–H). FAB-MS m/z:
268 (Mþ1)þ.
3.4.1. Anhydrolycorine (1). Pale yellow prisms, 110–
112.5 8C (EtOH), (lit.20a 108–111 8C). 1H NMR (200 MHz,
CDCl3) d: 3.02 (2H, t, J¼7.9 Hz, C4–H), 3.33 (2H, t,
J¼7.9 Hz, C5–H), 4.07 (2H, s, C7–H), 5.97 (2H, s,
OCH2O), 6.64 (1H, s, C8–H), 6.76 (1H, dd, J¼7.3,
7.3 Hz, C2–H), 7.01 (1H, dd, J¼1.0, 7.3 Hz, C3–H), 7.16
(1H, s, C11–H), 7.28 (1H, dd, J¼1.0, 7.3 Hz, C1–H). Anal.
calcd for C16H13NO2: C, 76.48; H, 5.21; N, 5.57. Found: C,
76.49; H, 5.43; N, 5.35.
3.4.7. Oxoassoanine (4). Colorless needles, mp 271–
273 8C (CHCl3–MeOH), (lit.20b 270–271 8C). 1H NMR
(200 MHz, CDCl3) d: 3.43 (2H, t, J¼8.3 Hz, C4–H), 4.04
(3H, s, OCH3), 4.08 (3H, s, OCH3), 4.49 (2H, t, J¼8.3 Hz,
C5–H), 7.20 (1H, dd, J¼7.4, 7.6 Hz, C2–H), 7.28 (1H, d,
J¼1.0, 7.4 Hz, C3–H), 7.52 (1H, s, C11–H), 7.80 (1H, d,
J¼1.0, 7.8 Hz, C1–H), 7.93 (1H, s, C8–H). Anal. calcd for
C17H15NO3: C, 72.58; H, 5.37; N, 4.98. Found: C, 72.43; H,
5.57; N, 5.03.
3.4.2. Anhydrolycorin-7-one (3). Pale brown needles, mp
236–237 8C (CHCl3–MeOH), (lit.20a 232–234 8C). 1H
NMR (200 MHz, CDCl3) d: 3.33 (2H, t, J¼8.3 Hz, C4–
H), 4.38 (2H, t, J¼8.3 Hz, C5–H), 6.05 (2H, s, OCH2O),
7.10 (1H, dd, J¼7.6, 7.6 Hz, C2–H), 7.20 (1H, dd, J¼1.2,
7.6 Hz, C3–H), 7.43 (1H, s, C11–H), 7.64 (1H, dd, J¼1.2,
7.6 Hz, C1–H), 7.82 (1H, s, C8–H). Anal. calcd for
C16H11NO3: C, 72.45; H, 4.18; N, 5.28. Found: C, 72.46;
H, 4.38; N, 5.21.
3.4.8. 1-(3,4-Dimethoxybenzyl)-2,3-dihydroindole (22).
Colorless needles, mp 77–78 8C (petr. ether). IR (CHCl3)
cm21: 1260, 1030. 1H NMR (200 MHz, CDCl3) d: 2.97 (2H,
t, J¼8.0 Hz, C3–H), 3.33 (2H, t, J¼8.0 Hz, C2–H), 3.86
(3H, s, OCH3), 3.88 (3H, s, OCH3), 4.21 (2H, s, Ar–CH2N),
6.62–7.14 (7H, m, Ar–H). FAB-MS m/z: 269 (M)þ. Anal.
calcd for C16H12BrNO2: C, 75.81; H, 7.11; N, 5.20. Found:
C, 75.78; H, 7.07; N, 5.19.
3.4.3. 1-[(1,3-Benzodioxol-5-yl)methyl]-2,3-dihydro-
indole (20). Pale yellow oil, (lit.19a oil). 1H NMR
(200 MHz, CDCl3) d: 2.96 (2H, t, J¼8.2 Hz, C3–H), 3.29
(2H, t, J¼8.2 Hz, C2–H), 4.16 (2H, s, Ar–CH2N), 5.95 (2H,
0
s, C2 –H), 6.51 (1H, d, J¼7.6 Hz, Ar–H), 6.63–7.11 (6H,
m, Ar–H). FAB-MS m/z: 253 (M)þ.
3.4.9. 1-(3,4-Dimethoxybenzyl)indole (23). Colorless
needles, mp 61.5–62.5 8C (hexane). IR (KBr) cm21: 1255,
1
3.4.4. 1-[(1,3-Benzodioxol-5-yl)methyl]indole (21a).
Colorless needles, mp 82–83 8C (petr. ether). IR
1025. H NMR (200 MHz, CDCl3) d: 3.77 (3H, s, OCH3),
3.84 (3H, s, OCH3), 5.25 (2H, s, Ar–CH2N), 6.53 (1H, d,
1
(KBr) cm21: 1235, 1040. H NMR (200 MHz, CDCl3) d:
J¼3.6 Hz, C3–H), 6.66–6.70 (2H, m, C2 –H and C6 –H),
0
0
0
5.22 (2H, s, Ar–CH2N), 5.91 (2H, s, C2 –H), 6.53 (1H, d,
0
6.78 (1H, d, J¼8.6 Hz, C5 –H), 7.10 (1H, ddd, J¼6.8,
0
J¼3.4 Hz, C3–H), 6.59 (1H, d, J¼1.4 Hz, C4 –H), 6.63
7.2 Hz, C5–H), 7.11 (1H, d, J¼3.6 Hz, C2–H), 7.18 (1H,
ddd, J¼1.4, 7.2, 8.0 Hz, C6–H), 7.31 (1H, d, J¼8.0 Hz, C7–
H), 7.64 (1H, dd, J¼1.4, 6.8 Hz, C4–H). FAB-MS m/z: 267
(M)þ. Anal. calcd for C16H12BrNO2: C, 76.38; H, 6.41; N,
5.24. Found: C, 76.28; H, 6.26; N, 5.20.
0
(1H, dd, J¼1.4, 7.8 Hz, C6 –H), 6.73 (1H, d, J¼7.8 Hz,
0
C7 –H), 7.10 (1H, ddd, J¼1.4, 6.8, 6.8 Hz, C5–H), 7.12
(1H, d, J¼3.4 Hz, C2–H), 7.18 (1H, ddd, J¼1.4, 6.8,
8.2 Hz, C6–H), 7.30 (1H, dd, J¼1.4, 8.2 Hz, C7–H), 7.64
(1H, dd, J¼1.4, 6.8 Hz, C4–H). FAB-MS m/z: 251 (M)þ.
Anal. calcd for C16H13NO2: C, 76.48; H, 5.21; N, 5.57.
Found: C, 76.32; H, 5.45; N, 5.49.
3.5. General procedure for the coupling reaction of 1-(2-
iodobenzyl)dihydroindole derivatives (16b and 17b)
under phosphine-free conditions (runs 6–8 in Table 3,
and runs 4 and 5 in Table 4)
3.4.5. 1-[(6-Bromo-1,3-benzodioxol-5-yl)methyl]indole
(21b). The residue of run 7 in Table 1 was dissolved in
CHCl3 and subjected to column chromatography through
silica gel. Elution with hexane–AcOEt (20:1) gave 21b,
colorless needles, mp 124.5–125.5 8C (hexane). IR
The 1-(2-iodobenzyl)dihydroindole derivative (0.3 mmol)
was reacted with 0.05 mol% of Pd(OAc)2, 100 mol% of
n-Bu4NCl, and 300 mol% of K2CO3 or 550 mmol% of